Publications by authors named "Gabriele Calizzani"

Claim this Profile
I
Improving access to haemophilia therapies-Beyond humanitarian aid.
Albert Farrugia, Giancarlo Liumbruno, Gabriele Calizzani, Fabio Candura, Samantha Profili

Haemophilia· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The increased demand for plasma-derived factor VIII in Italy.
Romano Arcieri, Gabriele Calizzani, Fabio Candura, Pier Mannuccio Mannucci

Blood Transfus· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recommendations for factor VIII product source to treat patients with haemophilia A.
Romano Arcieri, Gabriele Calizzani, Fabio Candura, Pier Mannuccio Mannucci

Blood Transfus· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibitor development in non-severe haemophilia across Europe.
Kathelijn Fischer, Alfonso Iorio, Riitta Lassila, Flora Peyvandi, Gabriele Calizzani

Thromb Haemost· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibitor development in haemophilia according to concentrate. Four-year results from the European HAemophilia Safety Surveillance (EUHASS) project.
Kathelijn Fischer, Riita Lassila, Flora Peyvandi, Gabriele Calizzani, Alex Gatt

Thromb Haemost· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human Parvovirus B19 and blood product safety: a tale of twenty years of improvements.
Giuseppe Marano, Stefania Vaglio, Simonetta Pupella, Giuseppina Facco, Gabriele Calizzani

Blood Transfus· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatitis E: an old infection with new implications.
Giuseppe Marano, Stefania Vaglio, Simonetta Pupella, Giuseppina Facco, Maria Bianchi, Gabriele Calizzani

Blood Transfus· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human Parvovirus B19 and blood product safety: a tale of twenty years of improvements.
Giuseppe Marano, Stefania Vaglio, Simonetta Pupella, Giuseppina Facco, Gabriele Calizzani

Blood Transfus· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Haemophilia Centre Certification Systems: optional or optimal choice for healthcare systems?
Gabriele Calizzani, Michael Makris, Pier Mannuccio Mannucci, Domenica Taruscio, Giuliano Grazzini

Blood Transfus· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Italian institutional accreditation model for Haemophilia Centres.
Gabriele Calizzani, Fabio Candura, Ivana Menichini, Romano Arcieri, Giancarlo Castaman

Blood Transfus· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The European Haemophilia Network (EUHANET).
Michael Makris, Gabriele Calizzani, Kathelijn Fischer, Alexander Gatt, Estelle Gilman

Blood Transfus· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The methodology for defining the European standards for the certification of Haemophilia Centres in Europe.
Fabio Candura, Ivana Menichini, Gabriele Calizzani, Paul Giangrande, Pier Mannuccio Mannucci

Blood Transfus· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The European standards of Haemophilia Centres.
Paul Giangrande, Gabriele Calizzani, Ivana Menichini, Fabio Candura, Pier Mannuccio Mannucci

Blood Transfus· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Uncovered needs in the management of inherited bleeding disorders in Italy.
Romano Arcieri, Angelo C Molinari, Stefania Farace, Giuseppe Mazza, Alberto Garnero, Gabriele Calizzani

Blood Transfus· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The social burden and quality of life of patients with haemophilia in Italy.
Yllka Kodra, Marianna Cavazza, Arrigo Schieppati, Marta De Santis, Patrizio Armeni, Gabriele Calizzani

Blood Transfus· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Definition of an organisational model for the prevention and reduction of health and social impacts of inherited bleeding disorders.
Gabriele Calizzani, Ivana Menichini, Fabio Candura, Monica Lanzoni, Samantha Profili

Blood Transfus· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma-derived medicinal products in Italy: information sources and flows.
Monica Lanzoni, Claudia Biffoli, Fabio Candura, Gabriele Calizzani, Stefania Vaglio

Blood Transfus· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sustainability of a public system for plasma collection, contract fractionation and plasma-derived medicinal product manufacturing.
Giuliano Grazzini, Anna Ceccarelli, Deanna Calteri, Liviana Catalano, Gabriele Calizzani

Blood Transfus· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The demand for human albumin in Italy.
Stefania Vaglio, Gabriele Calizzani, Monica Lanzoni, Fabio Candura, Samantha Profili

Blood Transfus· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The demand for polyvalent immunoglobulins in Italy.
Fabio Candura, Monica Lanzoni, Gabriele Calizzani, Samantha Profili, Stefania Vaglio

Blood Transfus· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The evolution of the regulatory framework for the plasma and plasma-derived medicinal products system in Italy.
Gabriele Calizzani, Stefania Vaglio, Fabio Candura, Samantha Profili, Monica Lanzoni

Blood Transfus· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The demand for factor VIII and for factor IX and the toll fractionation product surplus management.
Gabriele Calizzani, Samantha Profili, Fabio Candura, Monica Lanzoni, Stefania Vaglio

Blood Transfus· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Present and future challenges in the treatment of haemophilia: the patient's perspective.
Romano Arcieri, Angelo C Molinari, Stefania Farace, Giuseppe Mazza, Alberto Garnero, Gabriele Calizzani

Blood Transfus· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical use and the Italian demand for antithrombin.
Giancarlo M Liumbruno, Massimo Franchini, Monica Lanzoni, Fabio Candura, Stefania Vaglio, Gabriele Calizzani

Blood Transfus· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical use and the Italian demand for prothrombin complex concentrates.
Massimo Franchini, Giancarlo M Liumbruno, Monica Lanzoni, Fabio Candura, Stefania Vaglio, Gabriele Calizzani

Blood Transfus· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis